APA (7th ed.) Citation

Wu, B., Wu, H., Liu, X., Lin, H., & Li, J. (2014). Ranibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: A meta-analysis of randomised controlled trials. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Wu, Bin, Haixiang Wu, Xiaoyan Liu, Houwen Lin, and Jin Li. Ranibizumab Versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-analysis of Randomised Controlled Trials. Public Library of Science (PLoS), 2014.

MLA (9th ed.) Citation

Wu, Bin, et al. Ranibizumab Versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-analysis of Randomised Controlled Trials. Public Library of Science (PLoS), 2014.